Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032" report has...
-
Panic Disorder Market Towards US$ 12,621.61 Mn By 2030, A Comprehensive Analysis By Reports Insights
New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the panic disorder market is poised for strong expansion and is expected to reach USD 12,621.61 Million...
-
PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will...
-
Portland, OR, Aug. 06, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research,the antidepressant drugs market accounted for $13.75 billion in 2016, and is estimated to...
-
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Fluoxetine market is a thorough analysis of the size, share, demand, growth, gross profits, earnings, and revenue of the industry. It...
-
WASHINGTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- In a press release issued earlier today under the same headline, a person's name appeared incorrectly. The Social Void member should be Chip Cooley, not...
-
WASHINGTON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- The new e-novel PANIC is an uplifting tale of a young man navigating the emotional peaks and valleys of panic disorder. Yet according to its Washington,...
-
HICKSVILLE, NY. , July 09, 2018 (GLOBE NEWSWIRE) -- Canbiola, Inc. (OTC PINK: CANB) Canbiola is pleased to update shareholders on our progress for the first half of 2018. REVENUES: We expect...
-
PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...
-
DANVILLE, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Palo Alto Health Sciences (PAHS), maker of the Freespira Breathing System®, is excited to welcome Dr. Robert Cuyler as Chief Clinical Officer...